 I. To estimate the efficacy of GDC-0449 vismodegib treatment for adult patients with recurrent or refractory medulloblastoma, as measured by the objective response rates for patients without Stratum A and with Stratum B evidence of activation of Sonic Hedgehog SHH signaling pathway tumors. 